Remove Clinical Research Remove Clinical Trials Remove Cosmetics Remove FDA Compliance
article thumbnail

FDA End-of-Year Release of Warning Letters Impresses (or Depresses)

FDA Law Blog

If FDA wanted to create that impression, it likely succeeded. Warning Letters, generally made public in a batch each Tuesday, are FDA’s public sanction that is most widely used to bring pressure on manufacturers and clinical trial investigators. Patcos Cosmetics Pvt. Shah, M.D.,